Amprenavir

Medical Advocates
Amprenavir (Agenerase)

Main Page

New and Noteworthy
Agenerase PI
Fosamprenavir
Guidelines
Database of ARV Drug Interactions
Journal Data
Conference Data
Perinatal Data
Pediatric Data
Protease Inhibitors: General Data

ARVs Main Page

Main New/Newsworthy

Home Page

This web page is best viewed by using INTERNET EXPLORER
Last Update: January 02, 2011
Documents identified with this icon are in Portable Document Format (PDF) and require the Adobe Acrobat Reader

New and Noteworthy

April 2010

Effect of the HIV protease inhibitor amprenavir on the growth and differentiation of
primary gingival epithelium.
Israr M, Mitchell D, Alam S, et al Antivir Ther. 2010;15(2):253-65.

Perinatal Data

Guidelines

United States
Internet Documents

Public Health Service Task Force Recommendations for Use of Antiretroviral Drugs
in Pregnant HIV-Infected Women for Maternal Health and Interventions to Reduce
Perinatal HIV Transmission in the United States.
Perinatal HIV Guidelines Working Group.
November 2, 2007
Guidelines

Safety and Toxicity of Individual Antiretroviral Agents in Pregnancy
Perinatal HIV Guidelines Working Group.
November 2, 2007
Guidelines

ARVs Main Page Main New/Newsworthy Home Page